A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED
Withdrawn before enrolling
Conditions studied: XLHED
In brief
The proposed natural history study will enroll male patients with a diagnosis of XLHED, female carriers of XLHED and healthy volunteers. The study protocol will include collection of XLHED questionnaires and clinical outcomes using minimally invasive technologies. Data will be collected both retrospectively and prospectively. Clinical outcome assessments will be performed at the NFED Family Conference on July 11-12, 2019. Study participants will be able to complete XLHED questionnaires electronically ahead of the conference.
Key facts
- Study ID
- NCT03912792
- Run by
- Dermelix Biotherapeutics, LLC.
- People needed
- 0
- Starts
- 2019-06-28
- Expected to finish
- 2019-09-01
- Last updated by the study team
- 2019-07-02
Who can join
Age: any, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Informed Consent
- Males with XLHED, female carriers of XLHED and healthy volunteers
You may not qualify if…
- Treatment with an investigational study drug for XLHED
- Any major medical problems that would prevent her/him from participating in this study
- Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists (Examples: Urecholine, Salagen, Pilocar, and Provocholine)
- Pacemaker
Where it is running
- Chicago Marriott Lincolnshire Resort — Lincolnshire, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.